• Proteoform-Specific Drug Interactions in Native Membrane Sig

  2026-05-09

  This study pioneers the direct analysis of proteoform-specific interactions in native membrane environments, revealing how post-translational modifications and alternative splicing impact drug targeting. Using advanced mass spectrometry, the authors uncover differential off-target binding of PDE5 inhibitors, including Vardenafil, to distinct proteoforms, with implications for therapeutic selectivity and safety.

• Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei

  2026-05-08

  Unlock reliable protein phosphorylation preservation with Phosphatase Inhibitor Cocktail 3 (100X in DMSO), a robust serine/threonine phosphatase inhibitor for advanced signaling and phosphoprotein workflows. Learn how optimized protocols and troubleshooting tips can elevate your Western blot and phosphoprotein analysis, with APExBIO as your trusted partner.

• RNASEH1-AS1 as a Prognostic Biomarker in Hepatocellular Carc

  2026-05-08

  This study identifies the long non-coding RNA RNASEH1-AS1 as a clinically relevant biomarker and oncogenic target in hepatocellular carcinoma (HCC). Comprehensive bioinformatic and experimental analyses reveal RNASEH1-AS1 as an independent predictor of poor prognosis, highlighting its role in tumor progression and interaction with immune infiltrates.

• IPCRL1 Knockdown Attenuates Myocardial Ischemia/Reperfusion

  2026-05-07

  This study identifies the long noncoding RNA IPCRL1 as a key regulator in myocardial ischemia/reperfusion injury (MIRI). By elucidating the IPCRL1/miR-185-3p/JIP3 axis and its modulation of the JNK pathway, the research highlights a novel molecular target for cardioprotection.

• Scenario-Based Solutions with TUNEL Apoptosis Detection Kit

  2026-05-07

  This article delivers scenario-driven guidance for researchers using the TUNEL Apoptosis Detection Kit (DAB) (SKU K2271), addressing real-world laboratory challenges in apoptosis and DNA fragmentation analysis. Through practical Q&A and protocol recommendations, we demonstrate how SKU K2271 supports reproducible, high-sensitivity detection in diverse samples, grounded in evidence and best practices.

• Optimizing Apoptosis Assays with A-1331852 (SKU B6164): Scen

  2026-05-06

  This article provides a scenario-driven, evidence-based guide to leveraging A-1331852 (SKU B6164) as a high-affinity, selective BCL-XL inhibitor in apoptosis research and cancer studies. It addresses common laboratory challenges—such as assay sensitivity, workflow reproducibility, and vendor reliability—using real experimental contexts and literature-backed recommendations. Readers gain actionable strategies to improve data quality and experimental outcomes with A-1331852.

• PD 173074: Benchmarking FGFR/VEGFR2 Inhibition for Cancer Re

  2026-05-06

  PD 173074 delivers highly selective, nanomolar inhibition of FGFR1 and VEGFR2, making it a gold-standard tool for dissecting angiogenesis and tumor proliferation pathways. Its robust solubility profile and proven efficacy in both in vitro and in vivo models empower researchers to decode complex signaling in cancer and resistance studies.

• NHS-Biotin (A8002): Precision Protein Biotinylation for Rese

  2026-05-05

  NHS-Biotin (N-hydroxysuccinimido biotin) enables stable, site-specific biotinylation of antibodies and proteins via primary amines. Its short, uncharged spacer arm supports efficient intracellular and multimeric protein labeling, making it valuable for detection and purification in biochemical workflows. APExBIO’s NHS-Biotin (A8002) meets demanding research needs requiring minimal steric hindrance and high sensitivity.

• Mechanisms of Spiroplasma eriocheiris Entry into Drosophila

  2026-05-05

  This study elucidates how Spiroplasma eriocheiris invades Drosophila Schneider 2 cells, identifying clathrin-mediated endocytosis and macropinocytosis as key pathways. These findings inform experimental approaches to pathogen-host interactions and highlight potential intervention points in cell signaling relevant to infection biology.

• Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK Inhibition

  2026-05-04

  This study identifies Lnc21q22.11 as a novel long non-coding RNA that inhibits gastric cancer progression by interfering with the MEK/ERK signaling pathway. The findings highlight the mechanistic link between epigenetic regulation of lncRNAs and tumor suppression, with implications for future targeted therapies.

• Applied Workflows with LEE011 Succinate: Advancing CDK Inhib

  2026-05-04

  Ribociclib succinate (LEE011 succinate) empowers researchers with robust, reproducible cell cycle inhibition capabilities in HER2-positive metastatic breast cancer models. This guide delivers hands-on protocol enhancements, troubleshooting strategies, and key lessons from contemporary research—optimizing your use of this selective CDK inhibitor from APExBIO.

• Vardenafil HCl Trihydrate: Precision Tools for PDE5 Assays

  2026-05-03

  Vardenafil HCl Trihydrate empowers researchers to dissect cGMP signaling and smooth muscle relaxation with unmatched selectivity and reproducibility. Leveraging recent proteoform-specific insights, this guide details optimized workflows, troubleshooting strategies, and advanced assay applications for phosphodiesterase research.

• Optimal RIP3 Stoichiometry Tunes Necrosome Signal in Necropt

  2026-05-02

  This study reveals that necrosome assembly relies on a precise stoichiometry of RIP3 to RIP1, optimizing signal amplification and attenuation during necroptosis. Quantitative imaging and modeling uncover how supramolecular organization sets the threshold for cell death, offering new frameworks for dissecting regulated cell death and informing therapeutic modulation.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for Stable,

  2026-05-01

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) empowers researchers with robust, sensitive, and stable RNA labeling for advanced transcriptomic applications. This article uniquely examines the interplay between fluorescent RNA probe synthesis and the latest innovations in mRNA delivery and storage stability.

• Ampicillin Sodium: β-Lactam Antibiotic for Advanced Research

  2026-05-01

  Ampicillin sodium's high purity and robust inhibition of bacterial cell wall biosynthesis underpin its status as an indispensable β-lactam antibiotic for genetic selection, antibacterial activity assays, and resistance modeling. This article delivers applied workflows, troubleshooting insights, and protocol refinements, leveraging the unique strengths of APExBIO's Ampicillin sodium (A2510).

15348 records 8/1024 page Previous Next First page 上5页 678910 下5页 Last page